SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neopath (NPTH)
NPTH 0.0006000.0%Mar 7 3:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DPRLA who wrote (53)9/26/1997 12:04:00 PM
From: Sigmund   of 178
 
I should have added that I believe that they will be told in October if they are scheduled to go before the panel in November. I think they will go before the panel in November in that I believe they submitted the data 60 days before the panel meeting and I am told that that is a major factor i.e. giving the advisory panel enough time to review the data. But there may be other factors that impact the scheduling. Whether it be November or January/February probably doesn't make that much difference except that it impacts the timing of future revenues.

If they get this approval, I would imagine that the analysts will find it easier to be enthusiastic about the company.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News